MiR-150 promotes the proliferation and migration of lung cancer cells by targeting SRC kinase signalling inhibitor 1

European Journal of Cancer

Volumn 50, Issue 5, 2014, Pages 1013-1024

  Cao, Minghui ^a   Hou, Dongxia ^a   Liang, Hongwei ^a   Gong, Fei ^a   Wang, Yilei ^a   Yan, Xin ^b   Jiang, Xiaohong ^a   Wang, Chen ^a   Zhang, Junfeng ^a   Zen, Ke ^a   Zhang, Chen Yu ^a   Chen, Xi ^a  

^a NANJING UNIVERSITY   (China)

^b TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Lung cancer; Migration; miR 150; Proliferation; SRCIN1

Indexed keywords

ENZYME INHIBITOR; FOCAL ADHESION KINASE; MICRORNA; MICRORNA 150; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN TYROSINE KINASE; RAS PROTEIN; SRC KINASE SIGNALLING INHIBITOR 1; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL MIGRATION; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ADENOCARCINOMA; ONCOGENE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

LUNG CANCER; MIGRATION; MIR-150; PROLIFERATION; SRCIN1;

3' UNTRANSLATED REGIONS; ADAPTOR PROTEINS, VESICULAR TRANSPORT; AGED; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FEMALE; FOCAL ADHESION PROTEIN-TYROSINE KINASES; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE KNOCKDOWN TECHNIQUES; HUMANS; LUNG NEOPLASMS; MALE; MICRORNAS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; RAS PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE HOMOLOGY, NUCLEIC ACID; SIGNAL TRANSDUCTION; SRC-FAMILY KINASES;

EID: 84896702918     PISSN: 09598049     EISSN: 18790852     Source Type: Journal    
DOI: 10.1016/j.ejca.2013.12.024     Document Type: Article

References (40)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, and D. Forman Global cancer statistics CA Cancer J Clin 61 2 2011 69 90
2. D.M. Parkin, F. Bray, J. Ferlay, and P. Pisani Estimating the world cancer burden: Globocan 2000 Int J Cancer 94 2 2001 153 156
3. E.F. Patz Jr., P.C. Goodman, and G. Bepler Screening for lung cancer N Engl J Med 343 22 2000 1627 1633
4. D. Hanahan, and R.A. Weinberg Hallmarks of cancer: the next generation Cell 144 5 2011 646 674
5. S. Zochbauer-Muller, A.F. Gazdar, and J.D. Minna Molecular pathogenesis of lung cancer Annu Rev Physiol 64 2002 681 708
6. F.M. Johnson, and G.E. Gallick SRC family nonreceptor tyrosine kinases as molecular targets for cancer therapy Anticancer Agents Med Chem 7 6 2007 651 659
7. S.I. Rothschild, O. Gautschi, E.B. Haura, and F.M. Johnson Src inhibitors in lung cancer: current status and future directions Clin Lung Cancer 11 4 2010 238 242
8. R.B. Irby, and T.J. Yeatman Role of Src expression and activation in human cancer Oncogene 19 49 2000 5636 5642
9. M.C. Frame Src in cancer: deregulation and consequences for cell behaviour Biochim Biophys Acta 1602 2 2002 114 130
10. H. Piwnica-Worms, K.B. Saunders, T.M. Roberts, A.E. Smith, and S.H. Cheng Tyrosine phosphorylation regulates the biochemical and biological properties of pp60c-src Cell 49 1 1987 75 82
11. P. Di Stefano, S. Cabodi, and E. Boeri Erba et al. P130Cas-associated protein (p140Cap) as a new tyrosine-phosphorylated protein involved in cell spreading Mol Biol Cell 15 2 2004 787 800
12. S. Cabodi, M. del Pilar Camacho-Leal, P. Di Stefano, and P. Defilippi Integrin signalling adaptors: not only figurants in the cancer story Nat Rev Cancer 10 12 2010 858 870
13. P. Di Stefano, L. Damiano, and S. Cabodi et al. P140Cap protein suppresses tumour cell properties, regulating Csk and Src kinase activity EMBO J 26 12 2007 2843 2855
14. D. Repetto, S. Aramu, and E. Boeri Erba et al. Mapping of p140Cap phosphorylation sites: the EPLYA and EGLYA motifs have a key role in tyrosine phosphorylation and Csk binding, and are substrates of the Abl kinase PLoS One 8 1 2013 e54931
15. L. Damiano, P. Di Stefano, and M.P. Camacho Leal et al. P140Cap dual regulation of E-cadherin/EGFR cross-talk and Ras signalling in tumour cell scatter and proliferation Oncogene 29 25 2010 3677 3690
16. J. Krol, I. Loedige, and W. Filipowicz The widespread regulation of microRNA biogenesis, function and decay Nat Rev Genet 11 9 2010 597 610
17. G.A. Calin, and C.M. Croce MicroRNA signatures in human cancers Nat Rev Cancer 6 11 2006 857 866
18. A. Esquela-Kerscher, and F.J. Slack Oncomirs-microRNAs with a role in cancer Nat Rev Cancer 6 4 2006 259 269
19. P.Y. Lin, S.L. Yu, and P.C. Yang MicroRNA in lung cancer Br J Cancer 103 8 2010 1144 1148
20. J. Takamizawa, H. Konishi, and K. Yanagisawa et al. Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival Cancer Res 64 11 2004 3753 3756
21. Y. Hayashita, H. Osada, and Y. Tatematsu et al. A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation Cancer Res 65 21 2005 9628 9632
22. X. Liu, L.F. Sempere, and H. Ouyang et al. MicroRNA-31 functions as an oncogenic microRNA in mouse and human lung cancer cells by repressing specific tumor suppressors J Clin Invest 120 4 2010 1298 1309
23. B.P. Lewis, I.H. Shih, M.W. Jones-Rhoades, D.P. Bartel, and C.B. Burge Prediction of mammalian microRNA targets Cell 115 7 2003 787 798
24. B. John, A.J. Enright, A. Aravin, T. Tuschl, C. Sander, and D.S. Marks Human microRNA targets PLoS Biol 2 11 2004 e363
25. D.P. Bartel MicroRNAs: genomics, biogenesis, mechanism, and function Cell 116 2 2004 281 297
26. J.M. Summy, and G.E. Gallick Src family kinases in tumor progression and metastasis Cancer Metastasis Rev 22 4 2003 337 358
27. N.N. Mazurenko, E.A. Kogan, I.B. Zborovskaya, and F.L. Kisseljov Expression of pp60c-src in human small cell and non-small cell lung carcinomas Eur J Cancer 28 2-3 1992 372 377
28. T. Masaki, K. Igarashi, and M. Tokuda et al. Pp60c-src activation in lung adenocarcinoma Eur J Cancer 39 10 2003 1447 1455
29. L.C. Kim, L. Song, and E.B. Haura Src kinases as therapeutic targets for cancer Nat Rev Clin Oncol 6 10 2009 587 595
30. J.D. Bjorge, A. Jakymiw, and D.J. Fujita Selected glimpses into the activation and function of Src kinase Oncogene 19 49 2000 5620 5635
31. J.E. Thomas, P. Soriano, and J.S. Brugge Phosphorylation of c-Src on tyrosine 527 by another protein tyrosine kinase Science 254 5031 1991 568 571
32. S. Kennedy, M. Clynes, and P. Doolan et al. SNIP/p140Cap mRNA expression is an unfavourable prognostic factor in breast cancer and is not expressed in normal breast tissue Br J Cancer 98 10 2008 1641 1645
33. V. Fulci, S. Chiaretti, and M. Goldoni et al. Quantitative technologies establish a novel microRNA profile of chronic lymphocytic leukemia Blood 109 11 2007 4944 4951
34. Q. Wu, H. Jin, and Z. Yang et al. MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2 Biochem Biophys Res Commun 392 3 2010 340 345
35. L. Zhou, X. Qi, J.A. Potashkin, F.W. Abdul-Karim, and G.I. Gorodeski MicroRNAs miR-186 and miR-150 down-regulate expression of the pro-apoptotic purinergic P2X7 receptor by activation of instability sites at the 3′-untranslated region of the gene that decrease steady-state levels of the transcript J Biol Chem 283 42 2008 28274 28286
36. N. Yanaihara, N. Caplen, and E. Bowman et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis Cancer Cell 9 3 2006 189 198
37. P.Y. Wang, Y.J. Li, and S. Zhang et al. Regulating A549 cells growth by ASO inhibiting miRNA expression Mol Cell Biochem 339 1-2 2010 163 171
38. T. Yokobori, S. Suzuki, and N. Tanaka et al. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1 Cancer Sci 104 1 2013 48 54
39. S.K. Srivastava, A. Bhardwaj, and S. Singh et al. MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells Carcinogenesis 32 12 2011 1832 1839
40. C.M. Croce Causes and consequences of microRNA dysregulation in cancer Nat Rev Genet 10 10 2009 704 714